We've merged Palleos Healthcare to form a wide-reaching European CRO.
Find out more
OCT Clinical, a leading European CRO, continues its expansion into Eastern and Central Europe, with Estonia, Croatia and the Netherlands becoming a part of their global operational coverage. With a stream of new projects, the CRO has been forming new partnerships with major local laboratories, scientific sites and service companies within the listed countries. These collaborations contribute to an impeccable quality of research and provide global services for Phase I-IV and BE studies for international sponsors under the OCT banner without the risk entailed by acquisition or the cost of setting up in-country operations.
The importance of presence in an international arena cannot be overemphasized, as to date a growing number of U.S. pharmaceutical and biotech companies are starting to gain interest in conducting clinical trials overseas. Among the most compelling drivers for a new trial location search in non-core countries are the access to potentially eligible study subjects, including some complex and specific trials, faster project timelines and significant cost-saving options.
Each region and country has its own unique benefits and challenges, but strong expertise and focus on quality allow OCT to provide a full range of CRO services, including medical writing, consultancy, project management/monitoring, data management/biostatistics and turnkey service for clinical development. Today, the Eastern European CRO can take pride in its worldwide network with operations in more than 14 countries and more than 300 projects in the portfolio. This makes OCT Clinical a solid partner for drug developers and medical research institutions across a number of global locations.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
